Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis

Akihiro Murakami, Tatsushi Nakagawa, Chikako Ogawa, Mayumi Torii, Kotaro Sueoka, Shugo Nawata, Osamu Takeda, Hitoshi Ishikawa, Norihiro Sugino

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Squamous cell carcinoma antigen (SCCA) has been used or the management of squamous cell carcinoma, especially in order to evaluate therapeutic effects and monitor recurrence. Recent studies have shown that SCCA performs several biological functions and can influence the behavior of cancer cells. It is well known that altered expression of E-cadherin is involved in the process of cancer invasion and metastasis. The present study was therefore undertaken to investigate the relationship between the expression of SCCA, E-cadherin and lymph node metastasis in advanced cervical squamous cell carcinoma patients. We studied 70 patients who had undergone radical hysterectomy and pelvic lymphadenectomy for stage IB, IIA and IIB of the disease, without pretreatments. Immunohistochemistry, using monoclonal antibodies against SCCA2 and E-cadherin, was performed to examine the relationship between SCCA2 and E-cadherin expression patterns in primary cancer lesions and lymph node metastasis. There was a significant positive relationship between the two expression patterns in primary cancer lesions (p<0.01). Both exhibited a heterogeneous expression pattern in the primary tumor which indicated a significant relationship with lymph node metastasis (p<0.01). Our data clearly show that SCCA2 expression is significantly related to E-cadherin expression and that the heterogeneous pattern of SCCA and E-cadherin in primary lesions is strongly associated with the high incidence of lymph node metastasis in cervical squamous cell carcinoma. These findings suggest that SCCA2 may be involved in cancer behavior such as metastasis, and as such can be a useful marker in predicting lymph node metastasis.

Original languageEnglish
Pages (from-to)99-104
Number of pages6
JournalOncology Reports
Volume19
Issue number1
Publication statusPublished - Jan 1 2008
Externally publishedYes

Fingerprint

Cadherins
Uterine Cervical Neoplasms
Lymph Nodes
Neoplasm Metastasis
Squamous Cell Carcinoma
Neoplasms
Therapeutic Uses
squamous cell carcinoma-related antigen
Lymph Node Excision
Hysterectomy
Immunohistochemistry
Monoclonal Antibodies
Recurrence
Incidence

Keywords

  • E-cadherin
  • Lymph node metastasis
  • Squamous cell carcinoma antigen

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis. / Murakami, Akihiro; Nakagawa, Tatsushi; Ogawa, Chikako; Torii, Mayumi; Sueoka, Kotaro; Nawata, Shugo; Takeda, Osamu; Ishikawa, Hitoshi; Sugino, Norihiro.

In: Oncology Reports, Vol. 19, No. 1, 01.01.2008, p. 99-104.

Research output: Contribution to journalArticle

Murakami, A, Nakagawa, T, Ogawa, C, Torii, M, Sueoka, K, Nawata, S, Takeda, O, Ishikawa, H & Sugino, N 2008, 'Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis', Oncology Reports, vol. 19, no. 1, pp. 99-104.
Murakami, Akihiro ; Nakagawa, Tatsushi ; Ogawa, Chikako ; Torii, Mayumi ; Sueoka, Kotaro ; Nawata, Shugo ; Takeda, Osamu ; Ishikawa, Hitoshi ; Sugino, Norihiro. / Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis. In: Oncology Reports. 2008 ; Vol. 19, No. 1. pp. 99-104.
@article{325fddb6f8e54aacb544a939e2dbbd13,
title = "Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis",
abstract = "Squamous cell carcinoma antigen (SCCA) has been used or the management of squamous cell carcinoma, especially in order to evaluate therapeutic effects and monitor recurrence. Recent studies have shown that SCCA performs several biological functions and can influence the behavior of cancer cells. It is well known that altered expression of E-cadherin is involved in the process of cancer invasion and metastasis. The present study was therefore undertaken to investigate the relationship between the expression of SCCA, E-cadherin and lymph node metastasis in advanced cervical squamous cell carcinoma patients. We studied 70 patients who had undergone radical hysterectomy and pelvic lymphadenectomy for stage IB, IIA and IIB of the disease, without pretreatments. Immunohistochemistry, using monoclonal antibodies against SCCA2 and E-cadherin, was performed to examine the relationship between SCCA2 and E-cadherin expression patterns in primary cancer lesions and lymph node metastasis. There was a significant positive relationship between the two expression patterns in primary cancer lesions (p<0.01). Both exhibited a heterogeneous expression pattern in the primary tumor which indicated a significant relationship with lymph node metastasis (p<0.01). Our data clearly show that SCCA2 expression is significantly related to E-cadherin expression and that the heterogeneous pattern of SCCA and E-cadherin in primary lesions is strongly associated with the high incidence of lymph node metastasis in cervical squamous cell carcinoma. These findings suggest that SCCA2 may be involved in cancer behavior such as metastasis, and as such can be a useful marker in predicting lymph node metastasis.",
keywords = "E-cadherin, Lymph node metastasis, Squamous cell carcinoma antigen",
author = "Akihiro Murakami and Tatsushi Nakagawa and Chikako Ogawa and Mayumi Torii and Kotaro Sueoka and Shugo Nawata and Osamu Takeda and Hitoshi Ishikawa and Norihiro Sugino",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "19",
pages = "99--104",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis

AU - Murakami, Akihiro

AU - Nakagawa, Tatsushi

AU - Ogawa, Chikako

AU - Torii, Mayumi

AU - Sueoka, Kotaro

AU - Nawata, Shugo

AU - Takeda, Osamu

AU - Ishikawa, Hitoshi

AU - Sugino, Norihiro

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Squamous cell carcinoma antigen (SCCA) has been used or the management of squamous cell carcinoma, especially in order to evaluate therapeutic effects and monitor recurrence. Recent studies have shown that SCCA performs several biological functions and can influence the behavior of cancer cells. It is well known that altered expression of E-cadherin is involved in the process of cancer invasion and metastasis. The present study was therefore undertaken to investigate the relationship between the expression of SCCA, E-cadherin and lymph node metastasis in advanced cervical squamous cell carcinoma patients. We studied 70 patients who had undergone radical hysterectomy and pelvic lymphadenectomy for stage IB, IIA and IIB of the disease, without pretreatments. Immunohistochemistry, using monoclonal antibodies against SCCA2 and E-cadherin, was performed to examine the relationship between SCCA2 and E-cadherin expression patterns in primary cancer lesions and lymph node metastasis. There was a significant positive relationship between the two expression patterns in primary cancer lesions (p<0.01). Both exhibited a heterogeneous expression pattern in the primary tumor which indicated a significant relationship with lymph node metastasis (p<0.01). Our data clearly show that SCCA2 expression is significantly related to E-cadherin expression and that the heterogeneous pattern of SCCA and E-cadherin in primary lesions is strongly associated with the high incidence of lymph node metastasis in cervical squamous cell carcinoma. These findings suggest that SCCA2 may be involved in cancer behavior such as metastasis, and as such can be a useful marker in predicting lymph node metastasis.

AB - Squamous cell carcinoma antigen (SCCA) has been used or the management of squamous cell carcinoma, especially in order to evaluate therapeutic effects and monitor recurrence. Recent studies have shown that SCCA performs several biological functions and can influence the behavior of cancer cells. It is well known that altered expression of E-cadherin is involved in the process of cancer invasion and metastasis. The present study was therefore undertaken to investigate the relationship between the expression of SCCA, E-cadherin and lymph node metastasis in advanced cervical squamous cell carcinoma patients. We studied 70 patients who had undergone radical hysterectomy and pelvic lymphadenectomy for stage IB, IIA and IIB of the disease, without pretreatments. Immunohistochemistry, using monoclonal antibodies against SCCA2 and E-cadherin, was performed to examine the relationship between SCCA2 and E-cadherin expression patterns in primary cancer lesions and lymph node metastasis. There was a significant positive relationship between the two expression patterns in primary cancer lesions (p<0.01). Both exhibited a heterogeneous expression pattern in the primary tumor which indicated a significant relationship with lymph node metastasis (p<0.01). Our data clearly show that SCCA2 expression is significantly related to E-cadherin expression and that the heterogeneous pattern of SCCA and E-cadherin in primary lesions is strongly associated with the high incidence of lymph node metastasis in cervical squamous cell carcinoma. These findings suggest that SCCA2 may be involved in cancer behavior such as metastasis, and as such can be a useful marker in predicting lymph node metastasis.

KW - E-cadherin

KW - Lymph node metastasis

KW - Squamous cell carcinoma antigen

UR - http://www.scopus.com/inward/record.url?scp=38749108063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749108063&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 99

EP - 104

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 1

ER -